Fentanyl Transdermal System
Product Images NDC 42254-002

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Fentanyl Transdermal System (NDC 42254-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (A7c456e6 403b 4aae A576 60b106bf66a7 01)

Chemical structure diagram of the active ingredient in FENTANYL TRANSDERMAL SYSTEM, showing the molecular composition and arrangement of atoms including phenyl groups, nitrogen, and carbon chains.*

FDA Label Image

Patch Illustration (A7c456e6 403b 4aae A576 60b106bf66a7 02)

An illustration diagram showing the layered structure of the Fentanyl Transdermal System patch. Layers are labeled as backing film, drug containing layer, rate controlling membrane, skin adhesive layer, and protective liner, demonstrating the patch's multilayer design for controlled drug delivery.*

FDA Label Image

Serum Fentanyl Concentrations (A7c456e6 403b 4aae A576 60b106bf66a7 03)

A line and area plot depicting serum fentanyl concentrations (ng/mL) over time (Days 1 to 19) following multiple applications of a Fentanyl Transdermal System 100 mcg/hr. The chart is divided into three sections: repeat 72-hour applications, single 72-hour application, and after system removal, showing mean and range (group min to max) serum fentanyl levels.*

FDA Label Image

Patch Illustration (A7c456e6 403b 4aae A576 60b106bf66a7 04)

An instructional diagram of the Fentanyl Transdermal System showing its layered structure. It illustrates the backing film, drug containing layer, rate controlling membrane, skin adhesive layer, and protective liner, demonstrating the transdermal patch's component layout.*

FDA Label Image

Figure 1 (Patch applied to chest)

Black and white instructional photograph showing a male torso with a white rectangular transdermal patch applied to the upper chest area below the right shoulder. The image is labeled as Figure 1.*

FDA Label Image

Figure 2 (Patch applied to back)

An illustration showing a person’s upper back with a rectangular Fentanyl Transdermal System patch applied on the left shoulder blade area. The image demonstrates the correct placement site for the transdermal patch on the skin.*

FDA Label Image

Figure 3 (Patch applied to side)

Black and white photograph showing a male torso with a Fentanyl Transdermal System patch applied on the lower right abdomen near the waistline, demonstrating typical placement for the patch.*

FDA Label Image

Figure 4 (Patch applied to shoulder)

An illustration showing a person with a transdermal patch applied to the upper arm. This image demonstrates the use or placement of the Fentanyl Transdermal System patch on the skin.*

FDA Label Image

Figure 1 (Patch applied to chest)

Black and white instructional photograph showing the application of a FENTANYL TRANSDERMAL SYSTEM patch on the upper chest of a male subject. The patch is visible on the left pectoral area, indicating proper placement for transdermal delivery.*

FDA Label Image

Figure 2 (Patch applied to back)

A black and white illustration showing the back of a person with a rectangular fentanyl transdermal patch applied on the upper left side of the back.*

FDA Label Image

Figure 3 (Patch applied to side)

An illustration showing a man’s lower torso with a Fentanyl Transdermal System patch applied to the right side of the lower abdomen near the hip. The image demonstrates a possible application site for the transdermal patch.*

FDA Label Image

Figure 4 (Patch applied to shoulder)

Illustration showing a Fentanyl Transdermal System patch applied to the upper arm of a male torso. The image demonstrates the proper placement site for the transdermal patch.*

FDA Label Image

Figure 5 (Trimming chest hair)

An instructional black-and-white photograph showing a shirtless man holding a large pair of scissors near his chest, positioned as if about to cut something. This appears to be part of usage or removal instructions related to the FENTANYL TRANSDERMAL SYSTEM patch.*

FDA Label Image

Figure 6 (Tearing open a pouch)

An instructional black-and-white illustration labeled Figure 6 showing a pair of hands peeling back the protective liner from a Fentanyl Transdermal System patch, demonstrating how to prepare the patch for application.*

FDA Label Image

Figure 7 (Peeling the liner)

An instructional illustration depicting two hands peeling apart a translucent patch, demonstrating the opening or preparation of a transdermal system, related to FENTANYL TRANSDERMAL SYSTEM by Rebel Distributors Corp.*

FDA Label Image

Figure 8 (Applying patch to chest)

Illustration showing a man placing or pressing a transdermal system patch on his upper chest area. The image is labeled as Figure 8 and demonstrates correct placement of a patch, likely related to the FENTANYL TRANSDERMAL SYSTEM, though the patch itself is not clearly visible.*

FDA Label Image

Figure 9 (Folding patch)

An instructional diagram labeled Figure 9 showing a pair of hands holding and peeling apart a small clear plastic pouch, demonstrating how to open the packaging of a Fentanyl Transdermal System.*

FDA Label Image

Figure 10 (Flushing patch down a toilet)

Illustration labeled Figure 10 showing a hand holding a piece of material over the open bowl of a toilet. The image appears related to disposal instructions for the product.*

FDA Label Image

Fentanyl Transdermal System 50mcg/hr (A7c456e6 403b 4aae A576 60b106bf66a7 19)

Label of Fentanyl Transdermal System 50 mcg/hr by Rebel Distributors Corp. The label states in vivo delivery of 50 mcg/hr fentanyl for 72 hours, with each system containing 5.50 mg fentanyl. It includes NDC 42254-002-05 and storage instructions at 15°-30°C (59°-86°F). The product ID SF000205 is visible along with manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.